An artificial intelligence (AI)-driven screening tool successfully identified hospitalized adults at risk for opioid use ...

Somerville, Mass-based Mass General Brigham has rolled out ambient documentation using generative AI to help draft clinical ...

Startup K Health’s AI physician assistant matched doctors’ clinical decisions in two-thirds of patient cases, while offering ...

A study comparing artificial intelligence (AI)-driven clinical recommendations to physician decision-making for common acute ...

NIH-supported clinical trial shows AI tool as effective as healthcare providers in generating referrals to addiction specialists.

CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...

WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the release of Research Resilience Solutions, a site optimization initiative and ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

From diving into the ever-evolving landscape of AI in drug development to opening up the conversation to discuss regulatory hurdles and how the industry will overcome them, the Summit has been ...

Chart review has mostly been a manual process, has been prone to error, and is an area where extracting actionable insights ...

O-RAN ALLIANCE continues to uphold its core mission, ensuring that openness fosters interoperability and innovation to drive ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...